Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / CAPR - Capricor Therapeutics provides key updates on its COVID-19 vaccine programs

CAPR - Capricor Therapeutics provides key updates on its COVID-19 vaccine programs

Capricor Therapeutics Inc.
Capricor Therapeutics (CAPR) announces new updates on its vaccine and therapeutic development programs focused on COVID-19. The preclinical data describes the potential for Capricor’s multivalent exosome mRNA vaccine candidate for SARS-CoV-2 to generate a strong T-cell response against viral infection in addition to eliciting an antibody response. In addition, the company will announce topline data from its Phase 2 trial, INSPIRE, designed to assess the ability of CAP-1002 to modulate the cytokine storm and attenuate the sequelae caused by severe COVID-19 disease in Q1 2022.

For further details see:

Capricor Therapeutics provides key updates on its COVID-19 vaccine programs
Stock Information
Company Name: Capricor Therapeutics Inc.
Stock Symbol: CAPR
Market: NASDAQ
Website: capricor.com
Menu
CAPR CAPR Quote CAPR Short CAPR News CAPR Articles CAPR Message Board
Get CAPR Alerts

News, Short Squeeze, Breakout and More Instantly...